CIK 0001055726
- Non-accelerated filer
- Smaller reporting company
INOVIO PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- INO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330969592
- Phone
- +1 858-410-3134
- Business address
- 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
- Former names
- INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-06-05 | Humeau Laurent Chief Scientific Officer | Purchase | +20,000 | $2.50 | $50K | 45,833 |
| 2019-06-03 | Kim Jong Joseph Chief Executive Officer | Sale | −832,848 | $2.30 | $1.9M | 1,078,207 |
| 2019-06-03 | Kim Jong Joseph Chief Executive Officer | Sale | −296,705 | $2.31 | $685K | 816,527 |
| 2019-05-31 | Kim Jong Joseph Chief Executive Officer | Sale | −500,000 | $2.44 | $1.2M | 1,911,055 |
| 2019-05-31 | Kim Jong Joseph Chief Executive Officer | Sale | −500,000 | $2.40 | $1.2M | 1,113,232 |
| 2019-05-21 | Kim Jong Joseph Chief Executive Officer | Sale | −100,000 | $3.31 | $331K | 2,411,055 |
| 2019-05-16 | Kim Jong Joseph Chief Executive Officer | Sale | −61,212 | $3.50 | $214K | 1,613,232 |
| 2019-05-15 | Kim Jong Joseph Chief Executive Officer | Sale | −75,556 | $3.50 | $264K | 1,674,444 |
| 2019-05-11 | YARNO WENDY L Director | Exercise or conversion | +8,170 | 12,260 | ||
| 2019-05-11 | YARNO WENDY L Director | Exercise or conversion · Restricted Stock Unit | −8,170 | 0 | ||
| 2019-05-11 | BENITO SIMON X Director | Exercise or conversion | +8,170 | 43,637 | ||
| 2019-05-11 | BENITO SIMON X Director | Exercise or conversion · Restricted Stock Unit | −8,170 | 0 | ||
| 2019-05-11 | Cabrera Angel Director | Exercise or conversion | +8,170 | 67,589 | ||
| 2019-05-11 | Cabrera Angel Director | Exercise or conversion · Restricted Stock Unit | −8,170 | 0 | ||
| 2019-05-11 | Weiner David B. Director | Exercise or conversion | +8,170 | 813,462 | ||
| 2019-05-11 | Weiner David B. Director | Exercise or conversion · Restricted Stock Unit | −8,170 | 0 | ||
| 2019-05-11 | COLLINS MORTON Director | Exercise or conversion | +8,170 | 168,130 | ||
| 2019-05-11 | COLLINS MORTON Director | Exercise or conversion · Restricted Stock Unit | −8,170 | 0 | ||
| 2019-05-08 | Zoth Lota S. Director | Grant or award · Common Stock Options | +12,500 | 12,500 | ||
| 2019-05-08 | Zoth Lota S. Director | Grant or award · Restricted Stock Unit | +8,013 | 8,013 |
Page 34 of 49 · 961 trades